Novel loss of function mutation in KRIT1/CCM1 is associated with distinctly progressive cerebral and spinal cavernous malformations after radiochemotherapy for intracranial malignant germ cell tumor

Childs Nerv Syst. 2017 Aug;33(8):1275-1283. doi: 10.1007/s00381-017-3434-x. Epub 2017 May 9.

Abstract

Purpose: Cerebrospinal cavernous malformations (CCMs) are vascular lesions characterized by dilated and leaky capillary caverns. CCMs can cause seizures, focal neurological deficits or acute intracranial hemorrhage; however, most patients are asymptomatic. CCMs occur either sporadically or as a familial autosomal-dominant disorder. We present a clinical and molecular study of a patient with distinctive cerebral and spinal cavernous malformations following radiochemotherapy for a malignant brain tumor.

Methods: The patient had multiple magnet resonance imaging (MRI) examinations of his brain and spine following radiochemotherapy for a primary intracranial germ cell tumor (GCT), as part of his oncologic follow-up. The MRI sequences included susceptibility-weighted imaging (SWI). The coding exons and their flanking intronic regions of KRIT1/CCM1 gene were analyzed for mutations by polymerase chain reaction (PCR) and direct sequencing.

Results: MRI revealed numerous cerebral and spinal microhemorrhages and pronounced cavernous malformations that progressed with subsequent follow-up imaging. Genetic analysis demonstrated a novel heterozygous KRIT1/CCM1 two base pair deletion (c.1535_1536delTG) in exon 14. This deletion leads to a frameshift with a premature stop codon at nucleotide position 1553 and a highly likely loss of function of the KRIT1 protein.

Conclusion: We describe a patient with a novel heterozygous germ line loss of function mutation in KRIT1, which is associated with rapid-onset and highly progressive CCMs after radiochemotherapy for a malignant brain tumor.

Keywords: Angiogenesis; Late effects; Pediatric brain tumor; Radiation-induced cavernoma (RIC); Susceptibility-weighted imaging (SWI).

Publication types

  • Case Reports

MeSH terms

  • Chemoradiotherapy / adverse effects*
  • DNA Mutational Analysis
  • Follow-Up Studies
  • Hemangioma, Cavernous, Central Nervous System / diagnostic imaging
  • Hemangioma, Cavernous, Central Nervous System / etiology*
  • Hemangioma, Cavernous, Central Nervous System / genetics*
  • Humans
  • Image Processing, Computer-Assisted
  • KRIT1 Protein / genetics*
  • Loss of Function Mutation / genetics*
  • Magnetic Resonance Imaging
  • Male
  • Meningeal Neoplasms / genetics
  • Meningeal Neoplasms / therapy
  • Neoplasms, Germ Cell and Embryonal / genetics
  • Neoplasms, Germ Cell and Embryonal / therapy
  • Young Adult

Substances

  • KRIT1 Protein
  • KRIT1 protein, human